PlainRecalls
FDA Drug Critical Class I Completed

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

Reported: May 25, 2022 Initiated: April 5, 2022 #D-0882-2022

Product Description

Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59

Reason for Recall

TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.

Details

Recalling Firm
Cardinal Health Inc.
Units Affected
1 box
Distribution
NM only
Location
Dublin, OH

Frequently Asked Questions

What product was recalled?
Humalog KwikPen, Insulin lispro injection, U-100, 100 units per mL, 5x3 mL Prefilled Pens per box, Marketed by Lilly USA, LLC, Indianapolis, IN 46285, Box NDC 0002-8799-59, Pen NDC 002-7516-59. Recalled by Cardinal Health Inc.. Units affected: 1 box.
Why was this product recalled?
TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 25, 2022. Severity: Critical. Recall number: D-0882-2022.